Patients with MS often exhibit symptoms such as motor deficits, muscle weakness, sensory abnormalities, cognitive decline, and psychiatric abnormalities, which significantly affect the quality of life (Sturm et al., 2014)
In Conclusion Until there is more evidence-based research on the impact of GLC-1 receptor agonists on anesthesia, specifically conscious sedation, DOCS Education recommends a medical consult with the patients PCP or endocrinologist, and absent the strong recommendation to the contrary from their prescribing physician, have the patient withhold their weekly injectable GLP-1 receptor antagonist one week before sedation, and their daily GLP-1 receptor agonist on the day of the sedation appointment, and be NPO 6 hours before the appointment as usual
What patients report in our Doral consultations looks remarkably consistent from one person to the next, with the exact timing varying based on age, baseline body composition, sleep habits, and training load
1 2 "Structural basis for mammalian vitamin B12 transport by transcobalamin"